Radiographic Imaging of Human Papillomavirus Related Carcinomas of the Oropharynx

Head and Neck Pathology

Volumn 6, Issue SUPPL. 1, 2012, Pages 25-40

  Corey, Amanda S ^a   Hudgins, Patricia A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Computed tomography; Human papillomavirus related carcinoma; Oropharynx; Positron emission computed tomography; Squamous cell carcinoma

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; METHODOLOGY; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMANS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864141046     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-012-0374-3     Document Type: Review

References (27)

1. Osborne RG, Brown JJ. Carcinoma of the oral pharynx: an analysis of subsite treatment heterogeneity. Surg Oncol Clin N Am. 2004; 13: 71-80.
2. Filion E, Le Q-T. Oropharynx: epidemiology and treatment outcome. In: Harari PM, Connor NP, Grau C, editors. Functional preservation and quality of life in head and neck radiotherapy. Berlin: Springer; 2009.
3. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999-2008. CA Cancer J Clin. 2012 (epub ahead of print). doi: 10. 3322/caac. 20141.
4. Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011; 81: 12-20.
5. D'Souza F, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-56.
6. Chaturverdi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-301.
7. Lin DT, Cohen SM, Coppit GL, et al. Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clinc N Am. 2005; 38: 59-74.
8. Trotta BM, Pease CS, Rasamny JJ, et al. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics. 2011; 31: 339-54.
9. Cohan DM, Popat S, Kaplan SE, et al. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg. 2009; 17: 88-94.
10. Stambuk HE, Karimi S, Lee N, et al. Oral cavity and oropharynx tumors. Radiol Clin N Am. 2007; 45: 1-20.
11. Wesolowski JR, Mukherji S. Pathology of the pharynx. In: Som PM, Curtin HD, editors. Head and neck imaging. 5th ed. Amsterdam: Elsevier; 2011.
12. Edge S, Byrd D, Compton C, et al. AJCC7 cancer staging manual. New York: Springer; 2010.
13. Syms MJ, Birkmire-Peters DP, Holtel MR. Incidence of carcinoma in incidental tonsil asymmetry. Laryngoscope. 2000; 11: 1807-10.
14. 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol. 2009; 19: 634-43.
15. Xu G-Z, Zhu X-D, Li M-Y. Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis. Head Neck. 2011; 33: 87-94.
16. Bannas P, Habermann CR, Jung C, et al. Diagnostic accuracy of state-of-the-art MDCT scanners without gantry tilt in patient with oral and oropharyngeal cancer. Eur J Radiol. 2011;. doi: 10. 1016/j. ejrad. 2011. 07. 009.
17. Bhargava P, Rahman S, Wendt J. Atlas of confounding factors in head and neck PET/CT imaging. Clin Nucl Med. 2011; 36: e20-9.
18. Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck. Part 1. Physiologic, altered physiologic and artifactual FDG uptake. Radiographics. 2005; 25: 897-912.
19. Schmalbach CE, Miller FR. Occult primary head and neck cancer. Curr Oncol Rep. 2007; 9: 139-46.
20. Wong WL, Sonoda LI, Gharpurhy, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers-an audit and review of published studies. Clin Oncol. Available on-line 17 Dec 2011.
21. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-9.
22. Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009; 3: 78-81.
23. Goldenberg D, Begu S, Westra WH, et al. Cystic lymph node metastatsis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008; 30(7): 898-903.
24. Morani A, Shah G, Eisbruch A, et al. Intranodal cystic changes: a potential radiological signature/biomarker to assess the human papilloma virus status of patients with oropharyngeal carcinoma. AJR 2011; 196: A47. Abstract presented in scientific session 14-neuroradiology: head and neck on 4 May 2011 at the ARRS meeting.
25. Hudgins PA, Gillison M. Editorial: second branchial cleft cyst: NOT!! AJNR. 2009; 30: 1628-9.
26. Ahuga AT, Ying M. Sonographic evaluation of cervical lymph nodes. AJR. 2005; 184: 1691-9.
27. King KG, Kositwattanarerk A, Genden E, et al. Cancers of the oral cavity and oropharynx: FDG-PET with contrast enhanced CT in the posttreatment setting. Radiographics. 2011; 31: 355-73.